Skip to main content

Table 5 Change in mean blood pressure, lipid levels, and fasting glucose measures for participants who had abnormal levels at baseline

From: A real-world evaluation of a tertiary care childhood obesity intervention to reduce metabolic risk in a hard-to-reach urban population

Measure

Baseline Mean ± SD

Follow-up Mean ± SD

Difference (Δ) Mean (95% CI)

p value*

SBP (mm Hg)

122.6 ± 7.6

117.3 ± 11.3

−15.3(− 7.7, − 2.9)

p < 0.0001

DBP (mm Hg)

77.1 ± 7.7

67.6 ± 10.7

−9.6 (− 13.5, − 5.6)

p < 0.0001

TC (mg/dL)

196.0 ± 25.4

192.3 ± 32.0

−3.7 (− 9.8, 2.3)

p = 0.221

HDL (mg/dL)

36.2 ± 4.6

40.6 ± 8.8

4.4 (2.0, 6.8)

p < 0.001

LDL (mg/dL)

134.5 ± 19.4

126.7 ± 29.2

− 7.8 (− 15.1, − 0.55)

p = 0.036

TG (mg/dL)

140.8 ± 58.3

122.0 ± 49.2

−18.9 (− 41.8, 4.0)

p = 0.103

Glucose (mg/dL)

120.7 ± 27.4

91.7 ± 7.7

−29.0 (− 3.9, 0.99)

p = 0.054

  1. * p-values refer to paired-sample t-tests